Concepts (146)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cross Infection | 4 | 2023 | 331 | 1.250 |
Why?
|
| Disease Outbreaks | 3 | 2021 | 315 | 0.760 |
Why?
|
| Blood Culture | 1 | 2022 | 35 | 0.730 |
Why?
|
| Dermatomycoses | 1 | 2021 | 18 | 0.700 |
Why?
|
| Middle East Respiratory Syndrome Coronavirus | 1 | 2021 | 22 | 0.680 |
Why?
|
| Mucormycosis | 1 | 2021 | 31 | 0.680 |
Why?
|
| Antimicrobial Stewardship | 1 | 2022 | 88 | 0.670 |
Why?
|
| Neisseria meningitidis, Serogroup B | 1 | 2019 | 7 | 0.590 |
Why?
|
| Staphylococcal Food Poisoning | 1 | 2018 | 2 | 0.590 |
Why?
|
| Meningococcal Infections | 1 | 2019 | 21 | 0.580 |
Why?
|
| Cyclonic Storms | 1 | 2018 | 78 | 0.530 |
Why?
|
| Burkholderia cepacia complex | 1 | 2017 | 3 | 0.520 |
Why?
|
| Dioctyl Sulfosuccinic Acid | 1 | 2017 | 4 | 0.520 |
Why?
|
| Burkholderia Infections | 1 | 2017 | 8 | 0.520 |
Why?
|
| Drug Contamination | 1 | 2017 | 36 | 0.510 |
Why?
|
| Staphylococcus aureus | 1 | 2018 | 481 | 0.440 |
Why?
|
| Arthritis, Juvenile | 1 | 2015 | 45 | 0.440 |
Why?
|
| Tuberculoma, Intracranial | 1 | 2014 | 7 | 0.430 |
Why?
|
| Immune Reconstitution Inflammatory Syndrome | 1 | 2014 | 18 | 0.430 |
Why?
|
| Tuberculosis, Meningeal | 1 | 2014 | 31 | 0.420 |
Why?
|
| Vaccines | 1 | 2019 | 380 | 0.410 |
Why?
|
| Health Personnel | 1 | 2018 | 547 | 0.400 |
Why?
|
| Antitubercular Agents | 2 | 2014 | 265 | 0.390 |
Why?
|
| Texas | 8 | 2021 | 3631 | 0.380 |
Why?
|
| Infant | 15 | 2023 | 13302 | 0.370 |
Why?
|
| Urinary Tract Infections | 1 | 2016 | 327 | 0.360 |
Why?
|
| Tuberculosis Vaccines | 1 | 2011 | 13 | 0.360 |
Why?
|
| Tuberculin Test | 1 | 2011 | 120 | 0.340 |
Why?
|
| Mycobacterium tuberculosis | 2 | 2012 | 425 | 0.330 |
Why?
|
| Simplexvirus | 1 | 2011 | 100 | 0.330 |
Why?
|
| Herpes Simplex | 1 | 2011 | 56 | 0.330 |
Why?
|
| Anti-Bacterial Agents | 3 | 2022 | 2543 | 0.320 |
Why?
|
| Tuberculosis, Pulmonary | 1 | 2011 | 237 | 0.300 |
Why?
|
| Hospitals, Pediatric | 4 | 2021 | 800 | 0.270 |
Why?
|
| Child, Preschool | 11 | 2022 | 14994 | 0.270 |
Why?
|
| Disease Management | 1 | 2011 | 561 | 0.270 |
Why?
|
| Fetal Diseases | 1 | 2011 | 459 | 0.250 |
Why?
|
| Tuberculosis | 1 | 2012 | 555 | 0.240 |
Why?
|
| Vaccination | 1 | 2011 | 1034 | 0.240 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2011 | 489 | 0.240 |
Why?
|
| Fever of Unknown Origin | 2 | 2016 | 43 | 0.230 |
Why?
|
| Pneumonia, Viral | 2 | 2021 | 375 | 0.230 |
Why?
|
| Infant, Newborn | 8 | 2023 | 8554 | 0.220 |
Why?
|
| Humans | 23 | 2023 | 130599 | 0.210 |
Why?
|
| Zika Virus Infection | 2 | 2016 | 170 | 0.210 |
Why?
|
| Adolescent | 9 | 2022 | 20814 | 0.180 |
Why?
|
| Child | 11 | 2022 | 26182 | 0.180 |
Why?
|
| Rhizopus | 1 | 2021 | 10 | 0.180 |
Why?
|
| Metagenomics | 1 | 2022 | 115 | 0.170 |
Why?
|
| Sepsis | 2 | 2022 | 496 | 0.160 |
Why?
|
| Infection Control | 1 | 2021 | 161 | 0.160 |
Why?
|
| Food Microbiology | 1 | 2018 | 22 | 0.150 |
Why?
|
| Genotype | 2 | 2017 | 2609 | 0.150 |
Why?
|
| Female | 14 | 2022 | 70540 | 0.140 |
Why?
|
| Macrolides | 1 | 2018 | 31 | 0.140 |
Why?
|
| Frontal Sinusitis | 1 | 2018 | 4 | 0.140 |
Why?
|
| Zika Virus | 2 | 2016 | 149 | 0.140 |
Why?
|
| Rickettsia typhi | 1 | 2017 | 12 | 0.140 |
Why?
|
| Bacteremia | 1 | 2022 | 427 | 0.130 |
Why?
|
| Triazoles | 1 | 2018 | 143 | 0.130 |
Why?
|
| Infectious Disease Transmission, Vertical | 2 | 2016 | 253 | 0.130 |
Why?
|
| Typhus, Endemic Flea-Borne | 1 | 2017 | 28 | 0.130 |
Why?
|
| Orbital Diseases | 1 | 2018 | 66 | 0.130 |
Why?
|
| Betacoronavirus | 1 | 2020 | 285 | 0.130 |
Why?
|
| Polymerase Chain Reaction | 2 | 2017 | 1457 | 0.130 |
Why?
|
| Angiostrongylus cantonensis | 1 | 2016 | 8 | 0.130 |
Why?
|
| Strongylida Infections | 1 | 2016 | 14 | 0.120 |
Why?
|
| Students | 1 | 2019 | 246 | 0.120 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2022 | 915 | 0.120 |
Why?
|
| Young Adult | 6 | 2021 | 10011 | 0.120 |
Why?
|
| DNA, Bacterial | 1 | 2017 | 492 | 0.120 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2022 | 576 | 0.120 |
Why?
|
| Vesico-Ureteral Reflux | 1 | 2016 | 79 | 0.120 |
Why?
|
| Eye Abnormalities | 1 | 2016 | 103 | 0.120 |
Why?
|
| Antibodies, Bacterial | 1 | 2017 | 410 | 0.110 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 364 | 0.110 |
Why?
|
| Brain Diseases | 1 | 2018 | 302 | 0.110 |
Why?
|
| Feces | 1 | 2018 | 722 | 0.110 |
Why?
|
| Reoperation | 1 | 2018 | 841 | 0.110 |
Why?
|
| Immunocompetence | 1 | 2014 | 31 | 0.110 |
Why?
|
| Paresis | 1 | 2014 | 33 | 0.110 |
Why?
|
| Directly Observed Therapy | 1 | 2014 | 25 | 0.110 |
Why?
|
| Male | 10 | 2022 | 64580 | 0.110 |
Why?
|
| Cystic Fibrosis | 1 | 2017 | 267 | 0.100 |
Why?
|
| Ventriculoperitoneal Shunt | 1 | 2014 | 63 | 0.100 |
Why?
|
| Retrospective Studies | 6 | 2022 | 17654 | 0.100 |
Why?
|
| Fever | 1 | 2016 | 307 | 0.100 |
Why?
|
| Microcephaly | 1 | 2016 | 347 | 0.100 |
Why?
|
| Dexamethasone | 1 | 2014 | 253 | 0.100 |
Why?
|
| Congenital Abnormalities | 1 | 2016 | 317 | 0.100 |
Why?
|
| Glucocorticoids | 1 | 2014 | 341 | 0.090 |
Why?
|
| Infectious Disease Incubation Period | 1 | 2011 | 6 | 0.090 |
Why?
|
| World Health Organization | 1 | 2011 | 114 | 0.090 |
Why?
|
| Hydrocephalus | 1 | 2014 | 289 | 0.090 |
Why?
|
| HIV | 1 | 2011 | 177 | 0.080 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 1 | 2011 | 152 | 0.080 |
Why?
|
| Drug Administration Schedule | 1 | 2011 | 731 | 0.080 |
Why?
|
| Coinfection | 1 | 2011 | 188 | 0.080 |
Why?
|
| Eye | 1 | 2011 | 219 | 0.070 |
Why?
|
| Central Nervous System | 1 | 2011 | 274 | 0.070 |
Why?
|
| Disease Progression | 1 | 2014 | 2201 | 0.070 |
Why?
|
| Skin | 1 | 2011 | 547 | 0.070 |
Why?
|
| Recurrence | 1 | 2011 | 1477 | 0.070 |
Why?
|
| Clinical Trials as Topic | 1 | 2011 | 1131 | 0.060 |
Why?
|
| Delivery of Health Care | 2 | 2023 | 680 | 0.060 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2016 | 3864 | 0.060 |
Why?
|
| Postoperative Complications | 1 | 2018 | 3111 | 0.060 |
Why?
|
| Practice Guidelines as Topic | 1 | 2011 | 1299 | 0.050 |
Why?
|
| Patient Isolation | 1 | 2023 | 13 | 0.050 |
Why?
|
| Pandemics | 2 | 2021 | 1158 | 0.050 |
Why?
|
| Pregnancy | 2 | 2016 | 7495 | 0.050 |
Why?
|
| Infant Mortality | 1 | 2023 | 184 | 0.050 |
Why?
|
| Levofloxacin | 1 | 2022 | 49 | 0.040 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2022 | 116 | 0.040 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2023 | 340 | 0.040 |
Why?
|
| Diarrhea | 1 | 2022 | 312 | 0.040 |
Why?
|
| Immunocompromised Host | 1 | 2022 | 312 | 0.040 |
Why?
|
| HIV Infections | 1 | 2011 | 2014 | 0.040 |
Why?
|
| Anti-Infective Agents | 1 | 2022 | 265 | 0.040 |
Why?
|
| Opossums | 1 | 2017 | 8 | 0.030 |
Why?
|
| Administration, Intravenous | 1 | 2018 | 167 | 0.030 |
Why?
|
| Cats | 1 | 2017 | 119 | 0.030 |
Why?
|
| Proteus mirabilis | 1 | 2016 | 13 | 0.030 |
Why?
|
| Critical Illness | 1 | 2021 | 615 | 0.030 |
Why?
|
| Dogs | 1 | 2017 | 614 | 0.030 |
Why?
|
| Americas | 1 | 2016 | 51 | 0.030 |
Why?
|
| Brazil | 1 | 2016 | 117 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2018 | 698 | 0.030 |
Why?
|
| Methylprednisolone | 1 | 2016 | 95 | 0.030 |
Why?
|
| Meningitis | 1 | 2016 | 98 | 0.030 |
Why?
|
| Seasons | 1 | 2017 | 335 | 0.030 |
Why?
|
| Immunoglobulin M | 1 | 2016 | 209 | 0.030 |
Why?
|
| Prednisone | 1 | 2016 | 240 | 0.030 |
Why?
|
| Eosinophilia | 1 | 2016 | 107 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2022 | 5226 | 0.020 |
Why?
|
| Hospitalization | 1 | 2020 | 1934 | 0.020 |
Why?
|
| Antibodies, Viral | 1 | 2016 | 1166 | 0.020 |
Why?
|
| Prevalence | 1 | 2016 | 2682 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2018 | 6782 | 0.020 |
Why?
|
| Animals | 2 | 2017 | 33829 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2020 | 12901 | 0.010 |
Why?
|
| Risk Factors | 1 | 2018 | 10991 | 0.010 |
Why?
|
| United States | 1 | 2016 | 11814 | 0.010 |
Why?
|
| Aged | 1 | 2018 | 20939 | 0.010 |
Why?
|
| Middle Aged | 1 | 2018 | 28459 | 0.010 |
Why?
|
| Adult | 1 | 2018 | 31230 | 0.010 |
Why?
|